These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 35568607)

  • 1. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
    Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
    Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
    Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
    Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral lymph node dissection in rectal cancer: State of the art review.
    Hazen SJA; Sluckin TC; Konishi T; Kusters M
    Eur J Surg Oncol; 2022 Nov; 48(11):2315-2322. PubMed ID: 34802862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
    Miyakita H; Chan LF; Okada K; Kayano H; Mori M; Sadahiro S; Yamamoto S
    BMC Gastroenterol; 2022 Jul; 22(1):334. PubMed ID: 35804299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
    Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
    J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral lymph node dissection in advanced low rectal cancer treatment.
    Li J; Shiomi A
    Int J Colorectal Dis; 2021 Nov; 36(11):2361-2371. PubMed ID: 34152455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic versus laparoscopic approach for minimally invasive lateral pelvic lymph node dissection of advanced lower rectal cancer: a retrospective study comparing short-term outcomes.
    Ishizaki T; Mazaki J; Kasahara K; Udo R; Tago T; Nagakawa Y
    Tech Coloproctol; 2023 Jul; 27(7):579-587. PubMed ID: 37157049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients.
    Anania G; Davies RJ; Arezzo A; Bagolini F; D'Andrea V; Graziosi L; Di Saverio S; Popivanov G; Cheruiyot I; Cirocchi R; Donini A
    Int J Colorectal Dis; 2021 Nov; 36(11):2321-2333. PubMed ID: 34125269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Kim MJ; Chang GJ; Lim HK; Song MK; Park SC; Sohn DK; Chang HJ; Kim DY; Park JW; Jeong SY; Oh JH
    Ann Surg Oncol; 2020 Sep; 27(9):3525-3533. PubMed ID: 32385767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?
    Yang X; Gu C; Hu T; Bi L; Wei M; Deng X; Wang Z; Zhou Z
    ANZ J Surg; 2019 Nov; 89(11):E492-E497. PubMed ID: 31566296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
    Ishibe A; Watanabe J; Suwa Y; Suzuki S; Nakagawa K; Suwa H; Ozawa M; Ota M; Fujii S; Ike H; Ichikawa Y; Endo I
    Int J Colorectal Dis; 2021 Feb; 36(2):293-301. PubMed ID: 32965528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
    Law BZY; Yusuf Z; Ng YE; Aly EH
    Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.